id todo:paper_01455680_v55_n2_p140_Sampayo
record_format dspace
spelling todo:paper_01455680_v55_n2_p140_Sampayo2023-10-03T15:00:08Z Sevoflurane: Its action on heme metabolism and phase I drug metabolizing system Sampayo, R. Lavandera, J.V. Batlle, A. Buzaleh, A.M. 5-aminolevulinic acid synthetase Cytochrome P450 Heme metabolism PBG deaminase heme oxygenase Sevoflurane 5 aminolevulinate synthase cytochrome P450 2E1 heme heme oxygenase porphobilinogen deaminase sevoflurane acute intermittent porphyria animal experiment animal tissue article controlled study drug metabolism enzyme activity enzyme induction male mouse nonhuman oxidative stress Western blotting 5-Aminolevulinate Synthetase Anesthetics, Inhalation Animals Cytochrome P-450 CYP2E1 Heme Heme Oxygenase (Decyclizing) Hydroxymethylbilane Synthase Liver Male Methyl Ethers Mice Oxidative Stress Animalia Mus Acute attacks of porphyria are most commonly precipitated by events that decrease heme concentrations. Enzyme inducing-drugs are the most important triggering factors, particularly in relation to anaesthesia. We have reported previously that Enflurane and Isoflurane produced significant heme metabolism alterations, indicating that the use of these anaesthetics in porphyric patients should be avoided. The aim of this work was to evaluate the effect of the anaesthetic Sevoflurane on heme pathway and drug metabolizing Phase I system in mice. To this end, animals received different doses of the anaesthetic (1-2 ml/kg) and were sacrificed at different times (5-60 min). Data revealed important alterations in the enzymes involved in Acute Intermittent Porphyria, such as an induction in hepatic 5-Aminolevulinic acid synthetase activity and a diminished Porphobilinogen deaminase activity in liver and blood 20 minutes after Sevoflurane administration to mice in a dose of 1.5 ml/kg. Heme oxygenase activity was also induced, indicating the onset of oxidative stress. Total CYP levels and CYP2E1 expression were enhanced. As a consequence of these events, heme free pool would be depleted. In conclusion, our results in mice would suggest that Sevoflurane should be used with caution and very careful control in porphyric patients. Copyright © 2009 C.M.B. Edition. Fil:Lavandera, J.V. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Batlle, A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Buzaleh, A.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_01455680_v55_n2_p140_Sampayo
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic 5-aminolevulinic acid synthetase
Cytochrome P450
Heme metabolism
PBG deaminase heme oxygenase
Sevoflurane
5 aminolevulinate synthase
cytochrome P450 2E1
heme
heme oxygenase
porphobilinogen deaminase
sevoflurane
acute intermittent porphyria
animal experiment
animal tissue
article
controlled study
drug metabolism
enzyme activity
enzyme induction
male
mouse
nonhuman
oxidative stress
Western blotting
5-Aminolevulinate Synthetase
Anesthetics, Inhalation
Animals
Cytochrome P-450 CYP2E1
Heme
Heme Oxygenase (Decyclizing)
Hydroxymethylbilane Synthase
Liver
Male
Methyl Ethers
Mice
Oxidative Stress
Animalia
Mus
spellingShingle 5-aminolevulinic acid synthetase
Cytochrome P450
Heme metabolism
PBG deaminase heme oxygenase
Sevoflurane
5 aminolevulinate synthase
cytochrome P450 2E1
heme
heme oxygenase
porphobilinogen deaminase
sevoflurane
acute intermittent porphyria
animal experiment
animal tissue
article
controlled study
drug metabolism
enzyme activity
enzyme induction
male
mouse
nonhuman
oxidative stress
Western blotting
5-Aminolevulinate Synthetase
Anesthetics, Inhalation
Animals
Cytochrome P-450 CYP2E1
Heme
Heme Oxygenase (Decyclizing)
Hydroxymethylbilane Synthase
Liver
Male
Methyl Ethers
Mice
Oxidative Stress
Animalia
Mus
Sampayo, R.
Lavandera, J.V.
Batlle, A.
Buzaleh, A.M.
Sevoflurane: Its action on heme metabolism and phase I drug metabolizing system
topic_facet 5-aminolevulinic acid synthetase
Cytochrome P450
Heme metabolism
PBG deaminase heme oxygenase
Sevoflurane
5 aminolevulinate synthase
cytochrome P450 2E1
heme
heme oxygenase
porphobilinogen deaminase
sevoflurane
acute intermittent porphyria
animal experiment
animal tissue
article
controlled study
drug metabolism
enzyme activity
enzyme induction
male
mouse
nonhuman
oxidative stress
Western blotting
5-Aminolevulinate Synthetase
Anesthetics, Inhalation
Animals
Cytochrome P-450 CYP2E1
Heme
Heme Oxygenase (Decyclizing)
Hydroxymethylbilane Synthase
Liver
Male
Methyl Ethers
Mice
Oxidative Stress
Animalia
Mus
description Acute attacks of porphyria are most commonly precipitated by events that decrease heme concentrations. Enzyme inducing-drugs are the most important triggering factors, particularly in relation to anaesthesia. We have reported previously that Enflurane and Isoflurane produced significant heme metabolism alterations, indicating that the use of these anaesthetics in porphyric patients should be avoided. The aim of this work was to evaluate the effect of the anaesthetic Sevoflurane on heme pathway and drug metabolizing Phase I system in mice. To this end, animals received different doses of the anaesthetic (1-2 ml/kg) and were sacrificed at different times (5-60 min). Data revealed important alterations in the enzymes involved in Acute Intermittent Porphyria, such as an induction in hepatic 5-Aminolevulinic acid synthetase activity and a diminished Porphobilinogen deaminase activity in liver and blood 20 minutes after Sevoflurane administration to mice in a dose of 1.5 ml/kg. Heme oxygenase activity was also induced, indicating the onset of oxidative stress. Total CYP levels and CYP2E1 expression were enhanced. As a consequence of these events, heme free pool would be depleted. In conclusion, our results in mice would suggest that Sevoflurane should be used with caution and very careful control in porphyric patients. Copyright © 2009 C.M.B. Edition.
format JOUR
author Sampayo, R.
Lavandera, J.V.
Batlle, A.
Buzaleh, A.M.
author_facet Sampayo, R.
Lavandera, J.V.
Batlle, A.
Buzaleh, A.M.
author_sort Sampayo, R.
title Sevoflurane: Its action on heme metabolism and phase I drug metabolizing system
title_short Sevoflurane: Its action on heme metabolism and phase I drug metabolizing system
title_full Sevoflurane: Its action on heme metabolism and phase I drug metabolizing system
title_fullStr Sevoflurane: Its action on heme metabolism and phase I drug metabolizing system
title_full_unstemmed Sevoflurane: Its action on heme metabolism and phase I drug metabolizing system
title_sort sevoflurane: its action on heme metabolism and phase i drug metabolizing system
url http://hdl.handle.net/20.500.12110/paper_01455680_v55_n2_p140_Sampayo
work_keys_str_mv AT sampayor sevofluraneitsactiononhememetabolismandphaseidrugmetabolizingsystem
AT lavanderajv sevofluraneitsactiononhememetabolismandphaseidrugmetabolizingsystem
AT batllea sevofluraneitsactiononhememetabolismandphaseidrugmetabolizingsystem
AT buzaleham sevofluraneitsactiononhememetabolismandphaseidrugmetabolizingsystem
_version_ 1782026018991636480